Literature DB >> 11607790

Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1R.

A Sahagun-Ruiz1, J S Colla, J Juhn, J L Gao, P M Murphy, D H McDermott.   

Abstract

N-formylpeptides are phagocyte chemoattractants that act by binding to two structurally related receptors, FPR (formylpeptide receptor) and FPRL1R (FPR-like-1 receptor), which are encoded by the human genes FPR1 and FPRL1. Single nucleotide polymorphisms (SNPs) in the FPR coding region have been reported and two have been associated with the disease juvenile periodontitis; however, their frequency and linkage relationships are unknown. Here we systematically analyzed polymorphism in the open reading frames of FPR1 and FPRL1 by direct sequencing of cloned alleles from random blood donors from North America. For FPR1 we detected five non-synonymous SNPs and two synonymous SNPs in a sample of 26 chromosomes one each from 17 Caucasian and nine black random blood donors. Although all five non-synonymous SNPs were common in Caucasians, Blacks, and Asians, notable differences in allele frequency were found for each SNP in the different racial groups, suggesting differential selective pressures. We found that the FPR1 polymorphisms are linked in 15 common haplotypes. No polymorphisms were detected in FPRL1 after sampling 44 chromosomes from 36 random blood donors from the same three racial groups. Thus FPR1 and FPRL1, though they originated from a common gene, appear to have undergone markedly different evolutionary events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11607790     DOI: 10.1038/sj.gene.6363787

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  18 in total

1.  Formyl peptide receptor-mediated ERK1/2 activation occurs through G(i) and is not dependent on beta-arrestin1/2.

Authors:  Jeannie M Gripentrog; Heini M Miettinen
Journal:  Cell Signal       Date:  2007-11-09       Impact factor: 4.315

2.  The leukocyte chemotactic receptor FPR1 is functionally expressed on human lens epithelial cells.

Authors:  Erich H Schneider; Joseph D Weaver; Sonia S Gaur; Brajendra K Tripathi; Algirdas J Jesaitis; Peggy S Zelenka; Ji-Liang Gao; Philip M Murphy
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

Review 3.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

4.  Neutrophil formylpeptide receptor single nucleotide polymorphism 348T>C in aggressive periodontitis.

Authors:  Pooja Maney; Pinar Emecen; John S Mills; John D Walters
Journal:  J Periodontol       Date:  2009-03       Impact factor: 6.993

5.  Formylpeptide receptor single nucleotide polymorphism 348T>C and its relationship to polymorphonuclear leukocyte chemotaxis in aggressive periodontitis.

Authors:  Pooja Maney; John D Walters
Journal:  J Periodontol       Date:  2009-09       Impact factor: 6.993

6.  Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.

Authors:  Serena Boccella; Elisabetta Panza; Liliana Lista; Carmela Belardo; Angela Ianaro; Mario De Rosa; Vito de Novellis; Vincenzo Pavone
Journal:  Inflamm Res       Date:  2017-04-29       Impact factor: 4.575

7.  Regulation of human formyl peptide receptor 1 synthesis: role of single nucleotide polymorphisms, transcription factors, and inflammatory mediators.

Authors:  Heini M Miettinen
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

8.  Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor.

Authors:  John S Mills
Journal:  Biochim Biophys Acta       Date:  2006-06-06

9.  V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.

Authors:  Caihong Zhou; Yan Zhou; Jia Wang; Yang Feng; Haonan Wang; Jinglun Xue; Yani Chen; Richard D Ye; Ming-Wei Wang
Journal:  Biochem J       Date:  2013-04-15       Impact factor: 3.857

10.  Differential activation of polymorphisms of the formyl peptide receptor by formyl peptides.

Authors:  John S Mills
Journal:  Biochim Biophys Acta       Date:  2007-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.